Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Integra Lifesciences (NQ: IART )

23.66 +0.66 (+2.87%)
Streaming Delayed Price Updated: 3:16 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Integra Lifesciences

< Previous 1 2 3 4 5 6 7 8 Next >
IART INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Inquire About Securities Class Action Investigation – IART
From Rosen Law Firm
Via Business Wire
Why Integra LifeSciences Stock Is Crashing Today
Quality issues at one of Integra's facilities could be costly. 
Via The Motley Fool
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Analyst Ratings for Integra Lifesciences
Via Benzinga
Integra Lifesciences Earnings Perspective: Return On Capital Employed
Via Benzinga
Why Integra LifeSciences (IART) Stock Is Plunging Today
Integra LifeSciences Holdings Corp (NASDAQ: IART) reported  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Wall Street Stalls As Default Deadline Looms
Wall Street is lower this afternoon as the default debate rages on. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Via Benzinga
BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 30 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
What 6 Analyst Ratings Have To Say About Integra Lifesciences
Via Benzinga
Integra LifeSciences Shares Surge On Q3 Beat
Via Benzinga
Expert Ratings for Integra Lifesciences
Within the last quarter, Integra Lifesciences (NASDAQ:IART) has observed the following analyst ratings: 
Via Benzinga
Why Integra LifeSciences Stock Is Tumbling
Integra LifeSciences Holdings Corp (NASDAQ: IART) shares are trading lower Tuesday after the company initiated a voluntary global recall.  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
First Republic Bank, Activision Blizzard, Enphase Energy And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded mixed, with the Nasdaq Composite gaining over 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Wall Street Is Bullish on GE HealthCare as It Invests in AI
The stand-alone company that spun off from GE in January is off to a good start. 
Via The Motley Fool
Analyst Ratings for Integra Lifesciences
Within the last quarter, Integra Lifesciences (NASDAQ:IART) has observed the following analyst ratings: 
Via Benzinga
Integra LifeSciences Recalls CereLink Intracranial Pressure Monitors, Revises Guidance
Via Benzinga
Piper Sandler Cuts Price Target For Integra Lifesciences As It Divests Wound Care Portfolio
Via Benzinga
KB Home, Bed Bath & Beyond And 3 Stocks To Watch Heading Into Wednesday
With US stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Integra Lifesciences's Return On Capital Employed Overview
Pulled from Benzinga Pro data, Integra Lifesciences (NASDAQ:IART) posted Q3 earnings of $49.91 million, an increase from Q2 of 11.45%. Sales dropped to $385.19 million, a 3.17% decrease between... 
Via Benzinga
Integra Lifesciences: Q3 Earnings Insights
Integra Lifesciences (NASDAQ:IART) reported its Q3 earnings results on Wednesday, October 26, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
4 Analysts Have This to Say About Integra Lifesciences
Over the past 3 months, 4 analysts have published their opinion on Integra Lifesciences (NASDAQ:IART) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Integra Lifesciences's Return on Invested Capital Insights
According to Benzinga Pro, during Q2, Integra Lifesciences (NASDAQ:IART) earned $44.79 million, a 36.13% increase from the preceding quarter. Integra Lifesciences also posted a total of $397.81 million... 
Via Benzinga
Recap: Integra Lifesciences Q2 Earnings
  Integra Lifesciences (NASDAQ:IART) reported its Q2 earnings results on Wednesday, July 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Integra LifeSciences Posts Street Beating Earnings, Backs FY22 Guidance
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022
Upgrades 
Via Benzinga
Looking Into Integra Lifesciences's Return On Capital Employed
According to Benzinga Pro, during Q1, Integra Lifesciences (NASDAQ:IART) earned $32.90 million, a 27.51% increase from the preceding quarter. Integra Lifesciences's sales decreased to $376.64 million,... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.